Literature DB >> 16116650

Function follows form: the structure of the N-terminal domain of HCV NS5A.

Darius Moradpour1, Volker Brass, Francois Penin.   

Abstract

Hepatitis C virus (HCV) is a human pathogen affecting nearly 3% of the world's population. Chronic infections can lead to cirrhosis and liver cancer. The RNA replication machine of HCV is a multi-subunit membrane-associated complex. The nonstructural protein NS5A is an active component of HCV replicase, as well as a pivotal regulator of replication and a modulator of cellular processes ranging from innate immunity to dysregulated cell growth. NS5A is a large phosphoprotein (56-58 kd) with an amphipathic -helix at its amino terminus that promotes membrane association. After this helix region, NS5A is organized into 3 domains. The N-terminal domain (domain I) coordinates a single zinc atom per protein molecule. Mutations disrupting either the membrane anchor or zinc binding of NS5A are lethal for RNA replication. However, probing the role of NS5A in replication has been hampered by a lack of structural information about this multifunctional protein. Here we report the structure of NS5A domain I at 2.5-A resolution, which contains a novel fold, a new zinc-coordination motif, and a disulfide bond. We use molecular surface analysis to suggest the location of protein-, RNA-, and membrane-interaction sites.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16116650     DOI: 10.1002/hep.20851

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  20 in total

1.  Amphipathic alpha-helix AH2 is a major determinant for the oligomerization of hepatitis C virus nonstructural protein 4B.

Authors:  Jérôme Gouttenoire; Philippe Roingeard; François Penin; Darius Moradpour
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

Review 2.  Ultrastructural and biochemical basis for hepatitis C virus morphogenesis.

Authors:  Viviana Falcón; Nelson Acosta-Rivero; Sirenia González; Santiago Dueñas-Carrera; Gillian Martinez-Donato; Ivon Menéndez; Rocio Garateix; José A Silva; Emilio Acosta; Juan Kourı
Journal:  Virus Genes       Date:  2017-02-23       Impact factor: 2.332

3.  Visualization of double-stranded RNA in cells supporting hepatitis C virus RNA replication.

Authors:  Paul Targett-Adams; Steeve Boulant; John McLauchlan
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

4.  Intracellular Hepatitis C Virus Modeling Predicts Infection Dynamics and Viral Protein Mechanisms.

Authors:  Thomas R Aunins; Katherine A Marsh; Gitanjali Subramanya; Susan L Uprichard; Alan S Perelson; Anushree Chatterjee
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

5.  All three domains of the hepatitis C virus nonstructural NS5A protein contribute to RNA binding.

Authors:  Toshana L Foster; Tamara Belyaeva; Nicola J Stonehouse; Arwen R Pearson; Mark Harris
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

6.  Conserved determinants for membrane association of nonstructural protein 5A from hepatitis C virus and related viruses.

Authors:  Volker Brass; Zsuzsanna Pal; Nicolas Sapay; Gilbert Deléage; Hubert E Blum; François Penin; Darius Moradpour
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

Review 7.  An overview of HCV molecular biology, replication and immune responses.

Authors:  Usman A Ashfaq; Tariq Javed; Sidra Rehman; Zafar Nawaz; Sheikh Riazuddin
Journal:  Virol J       Date:  2011-04-11       Impact factor: 4.099

8.  Chronic hepatitis C.

Authors:  Jae Young Jang; Raymond T Chung
Journal:  Gut Liver       Date:  2011-06-24       Impact factor: 4.519

9.  Lipid metabolism and HCV infection.

Authors:  Paul Targett-Adams; Steeve Boulant; Mark W Douglas; John McLauchlan
Journal:  Viruses       Date:  2010-05-11       Impact factor: 5.818

10.  Antiviral therapy for hepatitis C virus: beyond the standard of care.

Authors:  Leen Delang; Lotte Coelmont; Johan Neyts
Journal:  Viruses       Date:  2010-03-29       Impact factor: 5.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.